A study evaluating role of whole body-Magnetic Resonance Imaging in early detection of thromboembolic events in Paroxysmal Nocturnal Hemoglobinuria patients treated with eculizumab .

Trial Profile

A study evaluating role of whole body-Magnetic Resonance Imaging in early detection of thromboembolic events in Paroxysmal Nocturnal Hemoglobinuria patients treated with eculizumab .

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Eculizumab (Primary)
  • Indications Paroxysmal nocturnal haemoglobinuria
  • Focus Diagnostic use
  • Most Recent Events

    • 10 Jan 2017 New trial record
    • 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top